An alkanecarboxylic acid derivative in the correction of immunopathological disorders in patients with multiple sclerosis associated with the activation of the human endogenous retrovirus HERV-E λ 4-1

Authors

  • I. A. Goldina Research Institute of Fundamental and Clinical Immunology, Novosibirsk, Russian Federation
  • E. V. Markova Research Institute of Fundamental and Clinical Immunology, Novosibirsk, Russian Federation

DOI:

https://doi.org/10.25557/2310-0435.2022.03.81-82

Keywords:

Neuroimmunopathology

Abstract

Conference abstract

Downloads

Published

2022-10-14

Issue

Vol. 20 No. 3 (2022): Pathogenesis

Section

Brief reports

How to Cite

1.
Goldina IA, Markova EV. An alkanecarboxylic acid derivative in the correction of immunopathological disorders in patients with multiple sclerosis associated with the activation of the human endogenous retrovirus HERV-E λ 4-1. Патогенез. 2022;20(3):81-82. doi:10.25557/2310-0435.2022.03.81-82